These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20542731)

  • 1. At a crossroads in oncology.
    Kamb A
    Curr Opin Pharmacol; 2010 Aug; 10(4):356-61. PubMed ID: 20542731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the unmet medical need: the Abbott Laboratories oncology approach.
    Carlson DM; Steinberg JL; Gordon G
    Clin Adv Hematol Oncol; 2005 Sep; 3(9):703-10. PubMed ID: 16224444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a case for selectively promiscuous anticancer drugs?
    Fernández A; Crespo A; Tiwari A
    Drug Discov Today; 2009 Jan; 14(1-2):1-5. PubMed ID: 19038361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new anti-cancer agents.
    Lobbezoo MW; Krul MR; Pinedo HM
    Forum (Genova); 1999; 9(3 Suppl 3):47-53. PubMed ID: 10607846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice.
    Martarelli D; Pompei P; Baldi C; Mazzoni G
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):809-17. PubMed ID: 17581752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular oncology--perspectives in lung cancer.
    Huber RM; Stratakis DF
    Lung Cancer; 2004 Aug; 45 Suppl 2():S209-13. PubMed ID: 15552801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
    Motadi LR; Misso NL; Dlamini Z; Bhoola KD
    Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New perspectives in cancer treatment].
    Brugarolas A; Giráldez J
    Rev Med Univ Navarra; 1998; 42(3):127-33. PubMed ID: 10420935
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitumorigenic effects of cannabinoids beyond apoptosis.
    Freimuth N; Ramer R; Hinz B
    J Pharmacol Exp Ther; 2010 Feb; 332(2):336-44. PubMed ID: 19889794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational research in oncology: key bottlenecks and new paradigms.
    Simon R
    Expert Rev Mol Med; 2010 Oct; 12():e32. PubMed ID: 20929594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular therapy targets in lung cancer].
    Le Guen Y; Sabatier L; Le Chevalier T; Soria JC
    Bull Cancer; 2003 Dec; 90(12):1055-61. PubMed ID: 14715425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple effects of bioflavonoids on gene regulation, cell proliferation and apoptosis: natural compounds move into the lime light of cancer research.
    Strissel PL; Strick R
    Leuk Res; 2005 Aug; 29(8):859-61. PubMed ID: 15967500
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel apoptosis inducing agents in cancer therapy.
    Mita M; Tolcher AW
    Curr Probl Cancer; 2005; 29(1):8-32. PubMed ID: 15672328
    [No Abstract]   [Full Text] [Related]  

  • 14. Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors.
    Seliger B; Massa C; Rini B; Ko J; Finke J
    Trends Mol Med; 2010 Apr; 16(4):184-92. PubMed ID: 20304705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches.
    Dumont F; Altmeyer A; Bischoff P
    Expert Opin Ther Pat; 2009 Jun; 19(6):775-99. PubMed ID: 19456277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer.
    Schultze A; Fiedler W
    Expert Opin Investig Drugs; 2010 Jun; 19(6):777-88. PubMed ID: 20465362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small cell lung cancer and targeted therapies.
    Blackhall FH; Shepherd FA
    Curr Opin Oncol; 2007 Mar; 19(2):103-8. PubMed ID: 17272981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Targeted anticancer drugs and their development].
    Kervinen J; Gahmberg CG
    Duodecim; 2004; 120(19):2323-30. PubMed ID: 15565985
    [No Abstract]   [Full Text] [Related]  

  • 19. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
    Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing development of new therapeutics for oncology.
    Winquist RJ; Boucher DM
    Curr Opin Pharmacol; 2010 Aug; 10(4):353-5. PubMed ID: 20634136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.